(资料图片)
Piper Sandler将艾伯维的目标价从231美元上调至284美元,维持“增持”评级。(格隆汇)
2025-10-11
2025-10-10
2025-10-09
2025-09-30
2025-09-29
2025-09-28
2025-09-27
2025-09-26
2025-09-25